Merck & Co., Inc.

$78.78
MRK - NYSE
Dividend yield
Dividend was reduced by 0.56% in last three years.
2.32 %
$1.77 anually
P/E ratio
-
Payout ratio
Proportion of net income paid out as dividends to shareholders
-
Yearly
Company profitability (EPS)
-
past 12 months
CASH payout ratio
Merck & Co., Inc. last quarter cash income being paid in the form of dividends.
Last quarter
Become our supporter to unlock all data!
Stock volatility (Beta)
See how volatile MRK stock is compared to other dividend stocks and to its sector
past 12 months
Become our supporter to unlock all data!
Company debt level
How much debt Merck & Co., Inc. have in comparison to other dividend stocks
Become our supporter to unlock all data!
Merck & Co., Inc. description

Merck & Co., Inc. engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, Healthcare Services, and Alliances. The Pharmaceutical segment includes human health pharmaceutical and vaccine products.

The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock and companion animal species, which it sells to veterinarians, distributors, and animal producers. The Healthcare Services segment offers services and solutions that focus on engagement, health analytics, and clinical services to improve the value of care delivered to patients. The Alliances segment includes results from the Company's relationship with AstraZeneca LP related to sales of Nexium and Prilosec.

The company was founded in 1891 and is headquartered in Kenilworth, NJ.

Company profile
Market cap
Mega (198.85B)
Company CEO
Kenneth C. Frazier
Price history Merck & Co., Inc.
Loading price stock history...
MRK dividends payouts
Similar stocks as Merck & Co., Inc.